Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Net assets
Net assets on the balance sheet as of September 2023 : -$12.42 M
According to Agile Therapeutics
's latest financial reports the company has -$12.42 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Agile Therapeutics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-5.55 M | -241.63% |
| 2021-12-31 | $3.91 M | -92.06% |
| 2020-12-31 | $49.32 M | 7.83% |
| 2019-12-31 | $45.74 M | 126.75% |
| 2018-12-31 | $20.17 M | -44.46% |
| 2017-12-31 | $36.32 M | -14.11% |
| 2016-12-31 | $42.28 M | 42.18% |
| 2015-12-31 | $29.74 M | -17.39% |
| 2014-12-31 | $36 M | -150.4% |
| 2013-12-31 | $-71.45 M | 21.9% |
| 2012-12-31 | $-58.61 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -554,237.46% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | -719,526.32% | 🇺🇸 USA |
 Merck MRK | $37.63 B | -303,339.06% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $28.05 M | -326.03% | 🇺🇸 USA |